Skip to main content
OpenTrials
Completed

NCT Number: NCT00982163

A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season

The study was designed to evaluate the pattern of seasonal allergic signs and symptoms consistent with ongoing ocular allergic inflammation during ragweed season. It was hypothesized that a pattern of ongoing ocular allergic inflammation existed in certain subjects.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

ORA, Inc.

North Andover, Massachusetts, 01845, United States

About this study

Subjects who had a positive skin test to ragweed within 24 months of Visit 1 were instructed to complete a diary, which assessed their allergic signs and symptoms 3 times a day for 4 weeks. During the in-office visits, subjects were asked to completed a quality of life questionnaire, as well as a retrospective and/or prospective eye allergy questionnaire.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects must:
  • be willing and able to read, sign, and date the informed consent and HIPAA documents prior to initiation of Visit 1 procedures or exams;
  • be at least 18 years of age;
  • be willing to avoid disallowed medication, such as anti-allergy therapies
  • have a positive history of ocular allergies and a positive skin test reaction to ragweed within the past 24 months;
  • have a calculated logMAR visual acuity score using the ETDRS Chart of 0.60 or better in each eye at Visit 1;

Exclusion criteria

  • Subjects may not:
  • have preauricular lymphadenopathy or any ocular condition that could affect study parameters (particularly, clinically significant blepharitis, follicular conjunctivitis and iritis);
  • have had any ocular infection within the last 30 days;
  • have a positive diagnosis of moderate to severe dry eye syndrome (i.e., requiring daily use of artificial tears);
  • wear contact lenses to each office visit; Note: Subjects will be allowed to use cold compresses.

Treatment and study plan

Primary outcomes

  1. Diary Data

    Time frame: 4 weeks

Sponsors and collaborators

Lead sponsor

ORA, Inc.

Industry

Registry information

Important dates

Study start
2008
Primary completion
2008
Study completion
2009
First posted
Sep 23, 2009
Registry last updated
Sep 23, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.